SABS
Price
$2.35
Change
+$0.05 (+2.17%)
Updated
Oct 15, 04:59 PM (EDT)
Capitalization
24.47M
Intraday Buy/Sell Signals
SLS
Price
$2.17
Change
+$0.12 (+5.85%)
Updated
Oct 15, 04:59 PM (EDT)
Capitalization
270.59M
27 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

SABS vs SLS

Header iconSABS vs SLS Comparison
Open Charts SABS vs SLSBanner chart's image
SAB Biotherapeutics
Price$2.35
Change+$0.05 (+2.17%)
Volume$11.16K
Capitalization24.47M
SELLAS Life Sciences Group
Price$2.17
Change+$0.12 (+5.85%)
Volume$62.76K
Capitalization270.59M
SABS vs SLS Comparison Chart in %
SABS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SABS vs. SLS commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SABS is a Hold and SLS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 16, 2025
Stock price -- (SABS: $2.30 vs. SLS: $2.16)
Brand notoriety: SABS and SLS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SABS: 41% vs. SLS: 282%
Market capitalization -- SABS: $24.47M vs. SLS: $270.59M
SABS [@Biotechnology] is valued at $24.47M. SLS’s [@Biotechnology] market capitalization is $270.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $104.58B to $0. The average market capitalization across the [@Biotechnology] industry is $2.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SABS’s FA Score shows that 0 FA rating(s) are green whileSLS’s FA Score has 0 green FA rating(s).

  • SABS’s FA Score: 0 green, 5 red.
  • SLS’s FA Score: 0 green, 5 red.
According to our system of comparison, both SABS and SLS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SABS’s TA Score shows that 6 TA indicator(s) are bullish while SLS’s TA Score has 5 bullish TA indicator(s).

  • SABS’s TA Score: 6 bullish, 4 bearish.
  • SLS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SABS is a better buy in the short-term than SLS.

Price Growth

SABS (@Biotechnology) experienced а -1.71% price change this week, while SLS (@Biotechnology) price change was +12.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.28%. For the same industry, the average monthly price growth was +18.38%, and the average quarterly price growth was +83.19%.

Reported Earning Dates

SLS is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+1.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLS($271M) has a higher market cap than SABS($24.5M). SLS YTD gains are higher at: 108.173 vs. SABS (-38.063). SLS has higher annual earnings (EBITDA): -27.18M vs. SABS (-33.47M). SLS has more cash in the bank: 25.3M vs. SABS (5.71M). SLS has less debt than SABS: SLS (737K) vs SABS (6.42M). SABS (0) and SLS (0) have equivalent revenues.
SABSSLSSABS / SLS
Capitalization24.5M271M9%
EBITDA-33.47M-27.18M123%
Gain YTD-38.063108.173-35%
P/E RatioN/AN/A-
Revenue00-
Total Cash5.71M25.3M23%
Total Debt6.42M737K871%
FUNDAMENTALS RATINGS
SLS: Fundamental Ratings
SLS
OUTLOOK RATING
1..100
27
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SABSSLS
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 1 day ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 9 days ago
72%
Bullish Trend 1 day ago
86%
Declines
ODDS (%)
Bearish Trend 17 days ago
86%
Bearish Trend 21 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
SABS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMVMF39.051.93
+5.20%
AMG Advanced Metallurgical Group NV
HLNCF4.570.12
+2.81%
HALEON PLC
AACAY5.060.01
+0.10%
AAC Technologies Holdings Inc
SYZLF3.94N/A
-0.10%
Sylogist Ltd.
HVGDF0.07-0.01
-7.27%
Harvest Gold Corp.

SABS and

Correlation & Price change

A.I.dvisor indicates that over the last year, SABS has been loosely correlated with LPTX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SABS jumps, then LPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SABS
1D Price
Change %
SABS100%
+2.17%
LPTX - SABS
46%
Loosely correlated
+0.50%
MGX - SABS
37%
Loosely correlated
+7.93%
TECX - SABS
30%
Poorly correlated
+7.77%
INKT - SABS
28%
Poorly correlated
+4.59%
SLS - SABS
27%
Poorly correlated
+5.61%
More